Abstract
We describe a new modality for administering aminoglycosides to hemodialysis (HD) patients, namely, a modification of the once-daily regimen which consists of administering the aminoglycosides over 60 min by drip infusion just before each HD session, with a preplanned peak concentration being reached at the beginning of the session and then with a rapidly decreasing concentration being achieved by the start of HD. The area under the concentration-time curve (AUC), i.e., the accumulation of the drug in the body, is thus minimized by this modality. Arbekacin (ABK) was given at a dose of 2 mg/kg of body weight to 10 HD patients infected with methicillin-resistant Staphylococcus aureus (MRSA) for 2 weeks (six sessions in total), resulting in the complete disappearance of MRSA in 5 patients. A high rate of elimination of ABK was attained for each patient while the patient was on HD (range, 0.20 to 0.42 h-1; mean 0.28 +/- 0.08 h-1) by using high-performance dialyzers provided with membranes made of either polymethylmethacrylate, cellulose triacetate (CTA), or ethylene vinyl alcohol. The best results were obtained with the CTA membrane, as revealed by the overall mass transfer coefficient (Ko). The AUC in the simulation model for the variation in the serum ABK concentration in this modality was calculated to be 40% of that of the conventional post-HD dosing modality, suggesting that a much higher dose could be administered to HD patients who receive HD thrice weekly (4 h per session), giving, e.g., 4 mg/kg initially and before the HD sessions, when there is an interval of 68 h from HD session to HD session, and giving 2 mg/kg before the other sessions.
Full Text
The Full Text of this article is available as a PDF (257.0 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Agarwal R., Toto R. D. Gentamicin clearance during hemodialysis: a comparison of high-efficiency cuprammonium rayon and conventional cellulose ester hemodialyzers. Am J Kidney Dis. 1993 Aug;22(2):296–299. doi: 10.1016/s0272-6386(12)70321-9. [DOI] [PubMed] [Google Scholar]
- Aoki Y. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin. Jpn J Antibiot. 1994 Jun;47(6):640–646. [PubMed] [Google Scholar]
- Begg E. J., Barclay M. L., Duffull S. B. A suggested approach to once-daily aminoglycoside dosing. Br J Clin Pharmacol. 1995 Jun;39(6):605–609. [PMC free article] [PubMed] [Google Scholar]
- Fillastre J. P., Leroy A., Humbert G., Moulin B., Bernadet P., Josse S. Pharmacokinetics of habekacin in patients with renal insufficiency. Antimicrob Agents Chemother. 1987 Apr;31(4):575–577. doi: 10.1128/aac.31.4.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gilbert D. N., Bennett W. M. Use of antimicrobial agents in renal failure. Infect Dis Clin North Am. 1989 Sep;3(3):517–531. [PubMed] [Google Scholar]
- Gilbert D. N. Once-daily aminoglycoside therapy. Antimicrob Agents Chemother. 1991 Mar;35(3):399–405. doi: 10.1128/aac.35.3.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hamilton-Miller J. M., Shah S. Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1995 Jun;35(6):865–868. doi: 10.1093/jac/35.6.865. [DOI] [PubMed] [Google Scholar]
- Hayashi I., Inoue M., Hashimoto H. Nationwide investigation in Japan on the efficacy of arbekacin in methicillin-resistant Staphylococcus aureus infections. Drugs Exp Clin Res. 1994;20(6):225–232. [PubMed] [Google Scholar]
- Kapusnik J. E., Sande M. A. Novel approaches for the use of aminoglycosides: the value of experimental models. J Antimicrob Chemother. 1986 Mar;17 (Suppl A):7–10. doi: 10.1093/jac/17.suppl_a.7. [DOI] [PubMed] [Google Scholar]
- Kondo S., Iinuma K., Yamamoto H., Ikeda Y., Maeda K. Letter: Synthesis of (S)-4-amino-2-hydroxybutyryl derivatives of 3',4'-dideoxykanamycin B and their antibacterial activities. J Antibiot (Tokyo) 1973 Nov;26(11):705–707. doi: 10.7164/antibiotics.26.705. [DOI] [PubMed] [Google Scholar]
- Michaels A. S. Operating parameters and performance criteria for hemodialyzers and other membrane-separation devices. Trans Am Soc Artif Intern Organs. 1966;12:387–392. [PubMed] [Google Scholar]
- Yourassowsky E., Van der Linden M. P., Crokaert F. One shot of high-dose amikacin: a working hypothesis. Chemotherapy. 1990;36(1):1–7. doi: 10.1159/000238741. [DOI] [PubMed] [Google Scholar]